Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
insulin glargine (toujeo) (4 trials)
insulin lispro (humalog) (2 trials)
glr2007 (1 trial)
gzr-18 (1 trial)
insulin aspart (Novolog) (1 trial)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Diabetes Mellitus (Phase 3)
Diabetes Mellitus, Type 1 (Phase 3)
Diabetes Mellitus, Type 2 (Phase 3)
Glioblastoma (Phase 2)
Trials (9 total)
Trial APIs (5 total)